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“Why Wouldn’t I Use It?”: Purdue Pharmaceutical’s Push of Pills  
Throughout the early 1940’s to mid 1960’s, the popular habit of smoking cigarettes was 
not only condoned, but advertised by doctors and lawmakers. With the support of medical 
professionals and non-restrictive advertisement laws, the widespread use of this deadly product 
exploded. The ‘Big Tobacco’ industry and the federal government made enormous amounts in 
profit and tax revenue. Numerous similarities can be found between the advertising of cigarettes 
and the prescription opioid, OxyContin. ‘Big Tobacco’ and the producer of OxyContin, Purdue 
Pharma (Hoffman and Williams Walsh), employed incredibly similar tactics to encourage the 
public to use their lethal products. By controlling the narrative about the potential dangers, and 
the addictive properties through their use of advertisements, both “Big Tobacco” and Purdue 
Pharmaceuticals accomplished their goals of inspiring the “why wouldn’t I use it” question in the 
consumers’ minds.   
 Through close manipulation of the public’s understanding about OxyContin, the entire 
nation, the United States, was deceived into believing that consuming the drug was as safe as it 
was effective. The misrepresentation of OxyContin in television commercials, magazine ads, 
branded promotional gifts and radio spots all painted a picture of a drug that would change lives 
for the better, through the popular tagline, “‘Remember, effective relief just takes two’” 
(Kelvey). The language used in this tagline implies that the substance is safe due to the low 
number of pills it takes to provide relief for a patient. What this phrase fails to mention is why it 
only “…just takes two” (Kelvey).   
Rather than the desirable, immediately pain-free lifestyle that the Purdue Pharmaceutical ads 
promoted, the lives of millions were destroyed by addiction and overdose. 
 In conjunction with the jaded portrayal of OxyContin to the general public, a massive 
effort by the Big Pharma enterprise heavily promoted the drug to physicians capable of 
prescribing opioids. An article published by Smithsonian Magazine, highlights the persuasive 
methods employed by Purdue Pharmaceuticals to change prior attitudes about prescribing such 
strong painkillers. “The real fire… was a behind-the-scenes effort to establish a laxer attitude 
toward prescribing opioid medications generally, one which made regulators and physicians 
alike more accepting of OxyContin” (Kelvey). By convincing physicians that OxyContin was not 
only a safe, but better alternative to other painkillers, Purdue Pharmaceuticals single-handedly 
increased the quantity prescribed of their drug. Making OxyContin far more accessible for 
patients through sale tactics such as giving free sample coupons, (Kelvey) supplemented their 
push of pills on a nationwide scale.  
By comparing a previous health crisis, the widespread use of cigarettes, it is apparent that 
advertising has had a major role in shaping the public’s opinion of dangerous substances. The 
promotion of the life-threatening habit of smoking cigarettes perfectly mirrors the promotion of 
the drug OxyContin. Both cigarette producers and Purdue Pharmaceuticals launched a rhetorical 
approach in their advertisements to appeal to consumer logic. Both Philip Morris cigarettes and 
Purdue Pharmaceuticals paid and supported physicians in exchange for the ability to advertise a 
doctor’s ‘seal of approval’. An article published by History.com highlighting the unethical 
marketing strategy employed by Philip Morris cigarettes states: ‘the Philip Morris company… ad 
claim[ed] doctors had conducted a study showing ‘when smokers changed to Philip Morris, 
every case of irritation cleared completely and definitely improved.’ What it didn’t mention was 
that Philip Morris had sponsored those doctors” (Little). This back-alley control over the positive 
language that was being used in advertisements is identical to the crooked sales tactics used by 
Purdue Pharmaceuticals.  
Mimicking the same tactic as the Philip Morris company, Purdue Pharmaceuticals also 
had their own privately funded physician, Dr. Sally Satel. The non-profit newsroom, ProPublica, 
exposed the convoluted relationship between OxyContin advocate Dr. Satel, and Purdue 
Pharmaceuticals for what it really was. Satel published numerous articles in support and defense 
of prescribing OxyContin as a safe pain management solution. To craft these seemingly credible 
arguments in support of the drug, Dr. Satel cited numerous studies and provided additional 
research from other doctors. The ProPublica article by David Armstrong, unearths Satel’s paid 
involvement with Purdue. Through close examination, it discovered that Satel’s cited sources 
and research were also funded by Purdue Pharmaceuticals (Armstrong). ‘Think Tanks’, doctors, 
and scientific researchers funded by the Big Pharma empire, were expected to produce evidence 
for reporters and healthcare professionals, like Satel, to use in hopes of swaying the public’s 
opinion and negating claims that the drug was highly addictive. These supposed “experts” in the 
field were paid to create intentionally biased content that would appear logical to the public due 
to the involvement of trusted medical professionals.   
Following a tactical approach to downplay the addictive nature of OxyContin by Purdue 
Pharmaceuticals, it successfully manifested itself in the intended use section of the in package 
insert (“Dope Dealers with White Lab Coats” [ 00:07:19]). Purdue Pharmaceuticals deliberately 
wrote the literature about the drug to be vague, therefore allowing significant amounts of the 
information to be left up to individual interpretation. According to the medication guide 
published by Purdue Pharma, "OxyContin is a strong prescription pain medicine… used to 
manage pain severe enough to require daily around-the-clock, long-term treatment with an 
opioid, when other pain treatments… do not treat your pain well enough or you cannot tolerate 
them” (Purdue Pharmaceuticals). Including language that can be perceived in numerous ways, 
such as the phrase “…do not treat your pain well enough or you cannot tolerate them” (Purdue 
Pharmaceuticals) allowed a network of corrupt physicians to justify their over-prescription of 
OxyContin.  
There is an immense amount of power that exists in controlling the narrative of a lethal 
substance, especially when vast amounts of money are involved. In the case of Purdue 
Pharmaceuticals, their billion-dollar drug empire (Armstrong) relied on the forfeiture of pertinent 
information to the public, and the spread of their version of the truth. A quantitative measure of 
this deliberate, focused push of OxyContin is seen when “sales grew from $48 million in 1996 to 
almost $1.1 billion in 2000” (Van Zee). The drastic one billion 52 million dollar increase in gross 
profit far exceeds the average increase in revenue when ethical marketing tactics are employed. 
When examining the information provided in OxyContin advertisements, which was produced 
by Purdue Pharmaceuticals, there were no warnings indicating that even appropriate usage can 
lead to a devastating addiction. 
The widespread and forceful push of prescription opioids by big pharmaceutical 
companies, such as Purdue Pharmaceuticals, resulted in a national opioid epidemic. Reformed 
drug advertisement laws and a monumental effort by the government judicial system as well as 
private sector drug addiction advocacy groups, sought to educate the public about the dangers of 
opioid usage. Unfortunately, these efforts have had little effect on curbing the rising number of 
prescription drug overdose related deaths. Purdue Pharmaceuticals had a large involvement in 
creating this national health epidemic by not disclosing all information about their drug in 
advertisements, manufacturing their own research to influence public opinion and creating a vast 
network of corrupt physicians to prescribe large quantities of the incredibly dangerous drug. All 
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